ArticleVaccines2026

Safety and Immunogenicity of SW-BIC-213, a Modified COVID-19 Lipo-Polyplex mRNA Vaccine, in Laotian Healthy Adults Aged 18 Years and Above: A Phase 1/2 Trial.

Ying Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.